Bringing Medicines to Market Faster Through Analytics & Machine Learning

 

Traditional medicine isn’t generally taken very seriously in the United States. However, Dr. Andrea Small-Howard, President and CSO at GB Sciences explained that “65% of the world still use traditional medicine either as their sole medicine or in conjunction with Western medicine.” Depending on the source, traditional plant-based medicine dates back as far as 60,000 years whereas Western medicine is a mere 3,000 years old.

Kevin Stevenson, I Don’t Care podcast host, sat down with the distinguished Dr. Small-Howard to discuss her work in the plant-based medicine industry. Dr. Small-Howard will also discuss the digital transformation curve with GB Sciences AI-based drug discovery platform PhAROS. This podcast is of great interest due in part to Dr. Small-Howard’s extensive resume. In fact, it is so extensive that the following introduction from her LinkedIn profile barely highlights her expertise.

“Dr. Andrea Small-Howard has 25 years of scientific research and executive experience in the biopharma industry supervising research & development, manufacturing, and quality control divisions in the US and China. Dr. Small-Howard has taken novel biological products from ideation through commercialization. She has been named an inventor on seventy+ patent applications, taken the lead in obtaining regulatory approvals from the U.S. Food and Drug Administration (‘US FDA’), and orchestrated commercial licensing deals.”

Listeners might think that they would not be able to understand or relate to such a well-educated scientific mind, but nothing could be further from the truth. Dr. Small-Howard is an engaging speaker filled with enthusiasm for her chosen line of work and her mission to normalize plant-based medicine in the United States.

“My background is in biochemistry, so I sort of see the world through a different lens and I’ve always been obsessed with the power of plant-based medicines. Traditional medicine is often overlooked as being a really powerful force here in the United States,” said Dr. Small-Howard. The doctor joined GB Sciences in 2014 to take plant-based medicine to the next level by utilizing science to maximize the potential of the cannabis plant.

More Like This Story:

Behavioral Health Is Stepping Out of the Shadows of Healthcare

Tearing Down the Barrier of Prior Authorization Through Automation

Follow us on social media for the latest updates in B2B!

Image

Latest

Fiber Deployment
Connected America 2025: Smarter Planning and Partnerships Key to Maximizing Fiber’s Federal Funding and Impact
March 31, 2025

As the digital divide accelerates and fiber deployment sees growth, Connected America 2025 has emerged as a pivotal moment for infrastructure professionals. With over $42.5 billion earmarked through federal programs like the Broadband Equity, Access, and Deployment (BEAD) initiative, the U.S. is undergoing one of the most aggressive broadband expansion efforts in its history….

Read More
Workplace safety
Building a Skilled Trades Workforce: Certifications, Simulation-Based Training & Reskilling with SkillCat
March 31, 2025

Industries across the United States are facing an unprecedented shortage of a skilled trades workforce. With millions of baby boomers retiring and fewer young people entering the trades, sectors like HVAC, manufacturing, and construction are grappling with a critical need for talent. This labor shortage is further compounded by a lack of awareness and…

Read More
K-12 school
Tackling All That K-12 Schools Try to Do: The Solutions
March 31, 2025

As public confidence in major institutions continues to erode, the American K–12 education system finds itself straining under the weight of legacy expectations and modern demands. From grading and college recommendations to extracurriculars and character development, K-12 schools are tasked with a near-impossible mission: to do it all, for everyone. At the same time,…

Read More
wellness
The Rise of AI-Powered Wellness: Vitaquest Taps Big Data to Deliver Personalized Nutrition at Scale
March 31, 2025

The wellness industry is at an inflection point. What once centered around pill packs and generic supplement regimens is now being transformed by an ecosystem of personalization, flavor innovation, and data-driven development. According to research, the global nutraceuticals market is on track to surpass $919 billion by 2030—and with consumer demand increasingly favoring tailored,…

Read More